Inhibitory effects of oral prednisolone and fexofenadine on skin responses by prick tests with histamine and compound 48/80

Journal of Dermatological Science

Volumn 30, Issue 3, 2002, Pages 180-184

  Inoue, Tomoko ^a   Katoh, Norito ^a   Kishimoto, Saburo ^a   Matsunaga, Kayoko ^b  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Compound 48 80; Fexofenadine; Histamine; Prednisolone; Prick test

Indexed keywords

ANTIHISTAMINIC AGENT; COMPOUND 48-80; CORTICOSTEROID; FEXOFENADINE; HISTAMINE; PREDNISOLONE; 4 METHOXY N METHYLPHENETHYLAMINE; ANTIALLERGIC AGENT; DIAGNOSTIC AGENT; DRUG DERIVATIVE; GLUCOCORTICOID; TERFENADINE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRICK TEST; PRIORITY JOURNAL; SKIN MANIFESTATION; URTICARIA; IMMEDIATE TYPE HYPERSENSITIVITY; ORAL DRUG ADMINISTRATION; SKIN TEST;

ADMINISTRATION, ORAL; ADULT; ANTI-ALLERGIC AGENTS; FEMALE; GLUCOCORTICOIDS; HISTAMINE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; MALE; P-METHOXY-N-METHYLPHENETHYLAMINE; PREDNISOLONE; SKIN TESTS; TERFENADINE;

EID: 0036890078     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(02)00069-5     Document Type: Article

References (21)

1. Mondroe E.W. Urticaria. Int. J. Dermatol. 20:1981;32-41.
2. Furue M., Terao H., Koga T. Effects of cetirizine and epinastine on the skin response to histamine iontophoresis. J. Dermatol. Sci. 25:2001;59-63.
3. Borici-Mazi R., Kouridakis S., Kontou-Fili K. Cutaneous responses to substance P and calcitonin gene-related peptide in chronic urticaria: the effect of cetirizine and dimethindene. Allergy. 54:1999;46-56.
4. Van Neste D., Coussement C., Ghys L., Rihoux J.P. Agonist-antagonist interactions in the skin: comparison of effects of loratadine and cetirizine on skin vascular responses to prick tests with histamine and substance P. J. Dermatol. Sci. 4:1992;172-179.
5. Cappugi P., Tsampau D., Lotti T. Substance P provokes cutaneous erythema and edema through a histamine-independent pathway. Int. J. Dermatol. 31:1992;206-209.
6. Coulson I.H., Holden C.A. Cutaneous reactions to substance P and histamine in atopic dermatitis. Br. J. Dermatol. 122:1990;343-349.
7. Olson R., Karpink M.H., Shelanski S., Atkins P.C., Zweiman B. Skin reactivity to codeine and histamine during prolonged corticosteroid therapy. J. Allergy Clin. Immunol. 86:1990;153-159.
8. Dreborg S. Skin test used in type 1 allergy testing, Position paper. Allergy. 44:1989;22-30.
9. Fadel R., Ramboer I., Chatterjee N., Rihoux J.P., Derde M.P. Cetirizine inhibits bradykinin-induced cutaneous wheal and flare in atopic and healthy subjects. Allergy. 55:2000;888-891.
10. Petersen L.J., Church M.K., Skov P.S. Histamine is released in the weal but not the flare following challenge of human skin in vivo: A microdialysis study. Clin. Exp. Allergy. 27:1997;284-295.
11. Lopez-Campos C., Rincon-Castaneda C.B., Cano-Rios P., Martinez-Ordaz V.A., Velasco-Rodriguez V.M. Is the histamine skin test inhibited by prednisone? Arch. Med. Res. 29:1998;63-65.
12. Makham A., Wagstaff A.J. Fexofenadine. Drugs. 55:1998;269-274.
13. Flower R.J., Blackwell G.J. Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin biosynthesis. Nature. 278:1979;456-459.
14. Goppelt-Struebe M., Wolter D., Resch K. Glucocorticoids inhibit prostaglandin synthesis not only at the level cyclo-oxygenase/PGE isomerase. Br. J. Pharmacol. 98:1989;1287-1295.
15. Oyanagui Y. Anti-inflammatory effects of polyamines in serotonin and carragreenan paw edemata-possible mechanism to increase vascular permeability inhibitory protein level which is regulated by glucocorticoids and superoxide radical. Agents Actions. 14:1984;228-237.
16. Inagaki N., Miura T., Nagai H., Ono Y., Koda A. Inhibition of vascular permeability increase in mice. Int. Arch. Allergy Appl. Immunol. 87:1988;254-259.
17. Sugio K., Ohuchi K., Sugata M., Tsurufuji S. Suppression by dexamethasone of vascular permeability responses induced with leukotrienes C and D in the rat skin. Prostaglandins. 21:1981;649-653.
18. Svensjö E., Roempke K. Time-dependent inhibition of bradykinin- and histamine-induced microvasucular permeability increase by local glucocorticoid treatment. Prog. Respir. Res. 19:1985;173-180.
19. Björk J., Goldschmidt T., Smedegard G., Arfors K.E. Methylprednisolone acts at the endtherial cell level reducing inflammatory responses. Acta Physiol. Scand. 123:1985;221-223.
20. Oyanagui Y., Suzuki S. Vasoregulin, a glucocorticoid-inducible vascular permability inhibitory protein. Agent Actions. 17:1985;270-277.
21. Di Rosa M., Calignano A., Carnuccio R., Ialenti A., Sautebin L. Multiple control of inflammation by glucocorticoids. Agents Actions. 17:1985;284-289.